Coloplast B A/S

COLO-B 
(NasdaqOMXC) 
 
dkk 640.40 <%= Resources.Global.txtUp %>
Updated 22/06/2018
Change % 1.91% Stock price increasing
Change 12.00 Stock price increasing
Volume 353,322
High DKK 640.40
Low DKK 630.20
Open DKK 630.60
ISIN DK0060448595
Prev close DKK 628.40
# of shares 198.00M
Market cap 126,799M DKK
Intraday

Market closed
Coloplast B A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  640.40 0.9% Stock price increasing 5.1% Stock price increasing 28.1% Stock price increasing 27.4% Stock price increasing 10.7% Stock price increasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
13,909
1,535
899
4,706
10,817
2014
12,428
3,147
2,390
6,283
10,379
2013
11,635
3,672
2,711
6,769
9,364
2012
11,023
3,255
2,194
6,042
10,176
2011
10,172
2,581
1,819
4,478
9,218
2010
9,537
1,995
1,243
3,452
7,771
2009
8,820
1,395
883
2,850
0
2008
8,463
994
715
2,290
0
2007
8,042
749
837
2,804
0
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Smith & Nephew PLC ORD USD0.20 1,392.50 1.8% Stock price increasing 3.4% Stock price increasing 7.2% Stock price increasing 7.7% Stock price increasing 1.7% Stock price increasing 8.1% Stock price increasing
 
Bristol-Myers Squibb Company 55.14 0.6% Stock price increasing 4.6% Stock price increasing -11.2% Stock price decreasing -9.5% Stock price decreasing -2.6% Stock price decreasing -10.0% Stock price decreasing
 
3M Company 196.50 -4.1% Stock price decreasing -1.5% Stock price decreasing -8.8% Stock price decreasing -16.3% Stock price decreasing -7.7% Stock price decreasing -16.5% Stock price decreasing
Indices Open
 
OMX Copenhagen 20 CAP 1,122.99 -0.9% Stock price decreasing -0.4% Stock price decreasing 1.2% Stock price increasing -1.8% Stock price decreasing -3.9% Stock price decreasing -1.8% Stock price decreasing

Company profile

Coloplast is a leading competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and wipes. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 66% of sales from Europe, 20% from North and South America, and 14% from the rest of the world.

Peers

Indices Last Change  
OMX C20 Cap 1,122.99 0.4% Stock price increasing
0,53,46,46,45,97,84,39,70,61
Instruments Last Change  
Smith & Neph.. 1,392.50 0.7% Stock price increasing
Bristol-Myer.. 55.14 2.2% Stock price increasing
3M Company 196.50 0.5% Stock price increasing

Targets for: Coloplast B A/S

Ritzau Finans
 
Analyst
Target
Date
Coloplast/HSBC: Hæver kursmålet til 585 kr. fra 557 kr.
HSBC
585 op
01/06/18
Coloplast/Credit Suisse: Kursmål op til 600 kr. fra 560 kr.
Credit Suisse
600 op
08/05/18
Coloplast/HSBC: Sænker kursmålet til 557 kr. fra 585 kr.
HSBC
557 op
26/03/18
Coloplast/Danske: Sænker kursmål til 575 kr. fra 620 kr.
Danske Bank
575 op
03/11/17
Coloplast/ABG: Sænker kursmål til 525 kr. efter regnskabsskuffelse
ABG Sundal Collier
525 op
03/11/17
Coloplast/Jefferies: Hæver kursmålet til 421 kr. fra 399 kr.
Jefferies
421 op
31/08/17

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 June 2018 17:47:22
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180619.1 - EUROWEB4 - 2018-06-24 18:47:22 - 2018-06-24 17:47:22 - 1000 - Website: OKAY